Matches in Wikidata for { <http://www.wikidata.org/entity/Q89561746> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q89561746 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89561746 description "scientific article published on 06 February 2020" @default.
- Q89561746 description "wetenschappelijk artikel" @default.
- Q89561746 description "наукова стаття, опублікована 6 лютого 2020" @default.
- Q89561746 name "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 name "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 type Item @default.
- Q89561746 label "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 label "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 prefLabel "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 prefLabel "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 P1433 Q89561746-6597F38E-9031-4EEF-877C-6C82B2766D04 @default.
- Q89561746 P1476 Q89561746-FCEA32AB-3960-4BD8-B46D-49F5A41D596C @default.
- Q89561746 P2093 Q89561746-0C020220-6F0C-4E4A-8B94-E98738E3B56B @default.
- Q89561746 P2093 Q89561746-3352D2C6-0B6E-46A5-A8A3-7AA28653DD9C @default.
- Q89561746 P2093 Q89561746-5963AF56-26B0-4D90-A25A-871A259C66F5 @default.
- Q89561746 P2093 Q89561746-62A92AB9-AA19-48C1-880A-57EF19B24F2C @default.
- Q89561746 P2093 Q89561746-729AD6E5-F525-43B2-95CD-6CCAD91DE91D @default.
- Q89561746 P2093 Q89561746-795212FC-0B5D-49F7-8453-9D3B7A20ED7D @default.
- Q89561746 P2093 Q89561746-9A8D10E8-25DE-421E-B705-1CC1EB17141D @default.
- Q89561746 P2093 Q89561746-AC057C7E-17CD-4248-878B-A9CEB152D8E6 @default.
- Q89561746 P2093 Q89561746-BEC2E825-0F50-4B20-B525-9EE5BF834B81 @default.
- Q89561746 P2093 Q89561746-D11CD06D-13FE-437F-927D-29D58C640749 @default.
- Q89561746 P2093 Q89561746-F6F04C11-D5F7-433D-993D-7D9B74EDCE55 @default.
- Q89561746 P31 Q89561746-70C11206-D0D3-4E59-B3C0-A556EA56414C @default.
- Q89561746 P356 Q89561746-2690A2B8-3456-4F28-B88B-B9C5C53301FB @default.
- Q89561746 P577 Q89561746-D8D8B149-320B-4586-882D-BE65D1586AD8 @default.
- Q89561746 P698 Q89561746-5630516F-3BA2-436E-9288-F94E61BCB384 @default.
- Q89561746 P356 S00223-019-00655-5 @default.
- Q89561746 P698 32025752 @default.
- Q89561746 P1433 Q5018771 @default.
- Q89561746 P1476 "Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice" @default.
- Q89561746 P2093 "Alicia Dessain" @default.
- Q89561746 P2093 "Catherine Nyssen-Behets" @default.
- Q89561746 P2093 "Daniel Chappard" @default.
- Q89561746 P2093 "Daniel H Manicourt" @default.
- Q89561746 P2093 "Guillaume Mabilleau" @default.
- Q89561746 P2093 "Jean-Pierre Devogelaer" @default.
- Q89561746 P2093 "Michael S Ominsky" @default.
- Q89561746 P2093 "Mickaël Cardinal" @default.
- Q89561746 P2093 "Patrick Ammann" @default.
- Q89561746 P2093 "Sébastien Lafont" @default.
- Q89561746 P2093 "Thomas Roels" @default.
- Q89561746 P31 Q13442814 @default.
- Q89561746 P356 "10.1007/S00223-019-00655-5" @default.
- Q89561746 P577 "2020-02-06T00:00:00Z" @default.
- Q89561746 P698 "32025752" @default.